Sanofi Share Price: SNY (Sanofi) Stock Price Today & Updates | INDmoney

Question 1

What is Sanofi share price today?

Accepted Answer

Sanofi (SNY) share price today is {{live_price}}.

Question 2

Can Indians buy Sanofi shares?

Accepted Answer

Yes, Indians can invest in the Sanofi (SNY) from India.

With INDmoney, you can buy Sanofi at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sanofi at zero transaction cost.

Question 3

How can I buy Sanofi shares from India?

Accepted Answer

It is very easy to buy Sanofi from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Sanofi be purchased?

Accepted Answer

Yes, you can buy fractional shares of Sanofi with INDmoney app.

Question 5

What are the documents required to start investing in Sanofi stocks?

Accepted Answer

To start investing in Sanofi, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Sanofi

Accepted Answer

Today’s highest price of Sanofi (SNY) is {{1_rba_end}}.

Today’s lowest price of Sanofi (SNY) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Sanofi

Accepted Answer

Today's market capitalisation of Sanofi SNY is 117.7B

Question 8

What is the 52 Week High and Low Range of Sanofi

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Sanofi is down from its 52 Week High?

Accepted Answer

Sanofi (SNY) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Sanofi is up from its 52 Week low?

Accepted Answer

Sanofi (SNY) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Sanofi?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Sanofi

Accepted Answer

Mr. Paul  Hudson is the current Chief Executive Officer (CEO) of Sanofi.

Period	Sanofi	Sector (Health Care)	Index (Russel 2000)
3 Months	-4.41%	1.9%	0.0%
6 Months	-8.87%	10.7%	0.0%
1 Year	-15.76%	4.6%	-1.1%
3 Years	-8.06%	14.2%	-22.1%

Market Capitalization	117.7B
Book Value	$59.17
Dividend Share	3.76
Dividend Yield	4.32%
Earnings Per Share (EPS)	2.29
PE Ratio	20.59
PEG Ratio	0.84
Wall Street Target Price	59.12

Profit Margin	11.73%
Operating Margin TTM	6.91%

Return On Assets TTM	4.54%
Return On Equity TTM	7.27%

Revenue TTM	46.0B
Revenue Per Share TTM	18.39
Quarterly Revenue Growth YOY	2.9000000000000004%
Gross Profit TTM	31.7B
EBITDA	12.5B
Diluted Eps TTM	2.29
Quarterly Earnings Growth YOY	0.22

Sanofi (SNY)

Increasing Revenue

Decreasing Net Profit

Vs LLY

Vs LLY

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Sanofi Dividends September,2024

Company Information

Discover More

FAQs

EPS Estimate Current Year	4.19
EPS Estimate Next Year	4.81
EPS Estimate Current Quarter	1.5
EPS Estimate Next Quarter	0.0

	FY18	Y/Y Change
Revenue	40.8B	↓ 1.5%
Net Income	4.9B	↑ 10.58%
Net Profit Margin	12.07%	↑ 1.32%

	FY19	Y/Y Change
Revenue	42.2B	↑ 5.48%
Net Income	3.1B	↓ 34.84%
Net Profit Margin	7.46%	↓ 4.61%

	FY20	Y/Y Change
Revenue	46.0B	↓ 0.7%
Net Income	15.1B	↑ 338.13%
Net Profit Margin	32.9%	↑ 25.44%

	FY21	Y/Y Change
Revenue	44.4B	↑ 4.83%
Net Income	7.0B	↓ 49.38%
Net Profit Margin	15.89%	↓ 17.01%

	FY22	Y/Y Change
Revenue	48.6B	↑ 15.86%
Net Income	9.0B	↑ 34.52%
Net Profit Margin	18.44%	↑ 2.55%

	FY23	Y/Y Change
Revenue	43.1B	↓ 5.11%
Net Income	5.4B	↓ 35.49%
Net Profit Margin	12.54%	↓ 5.9%

	Q3 FY22	Q/Q Change
Revenue	12.9B	↑ 22.3%
Net Income	2.0B	↑ 76.68%
Net Profit Margin	15.8%	↑ 4.86%

	Q4 FY22	Q/Q Change
Revenue	12.3B	↓ 12.8%
Net Income	3.3B	↑ 49.86%
Net Profit Margin	27.16%	↑ 11.36%

	Q1 FY23	Q/Q Change
Revenue	11.8B	↓ 5.18%
Net Income	2.2B	↓ 35.87%
Net Profit Margin	18.37%	↓ 8.79%

	FY18	Y/Y Change
Total Assets	127.5B	↑ 11.6%
Total Liabilities	59.9B	↑ 25.98%

	FY19	Y/Y Change
Total Assets	126.3B	↑ 1.19%
Total Liabilities	59.8B	↑ 1.96%

	FY20	Y/Y Change
Total Assets	140.9B	↑ 1.59%
Total Liabilities	62.9B	↓ 4.19%

	FY21	Y/Y Change
Total Assets	136.2B	↑ 4.99%
Total Liabilities	58.0B	↑ 0.1%

	Q2 FY23	Q/Q Change
Revenue	11.7B	↓ 1.67%
Net Income	1.6B	↓ 28.07%
Net Profit Margin	13.43%	↓ 4.94%

	Q3 FY23	Q/Q Change
Revenue	12.7B	↑ 18.87%
Net Income	2.5B	↑ 75.96%
Net Profit Margin	19.89%	↑ 6.46%

	Q4 FY23	Q/Q Change
Revenue	22.9B	↑ 80.21%
Net Income	2.0B	↓ 21.98%
Net Profit Margin	8.61%	↓ 11.28%

	FY18	Y/Y Change
Operating Cash Flow	6.3B	↓ 24.83%
Investing Cash Flow	-14.7B	↑ 344.27%
Financing Cash Flow	4.5B	↓ 149.78%

	FY19	Y/Y Change
Operating Cash Flow	8.6B	↑ 39.08%
Investing Cash Flow	-1.4B	↓ 90.58%
Financing Cash Flow	-4.7B	↓ 206.58%

	FY20	Y/Y Change
Operating Cash Flow	9.1B	↓ 3.85%
Investing Cash Flow	4.4B	↓ 396.04%
Financing Cash Flow	-8.0B	↑ 54.66%

	FY21	Y/Y Change
Operating Cash Flow	11.9B	↑ 41.84%
Investing Cash Flow	-8.3B	↓ 303.4%
Financing Cash Flow	-8.0B	↑ 8.8%

	FY22	Y/Y Change
Operating Cash Flow	11.3B	↑ 0.04%
Investing Cash Flow	-2.2B	↓ 71.57%
Financing Cash Flow	-6.2B	↓ 17.5%

	Q4 FY19	Q/Q Change
Operating Cash Flow	8.7B	-
Investing Cash Flow	-1.2B	-
Financing Cash Flow	-4.7B	-

	Q1 FY20	Q/Q Change
Operating Cash Flow	0.0	↓ 100.0%
Investing Cash Flow	0.0	↓ 100.0%
Financing Cash Flow	0.0	↓ 100.0%

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sanofi	-3.54%	-8.87%	-15.76%	-8.06%	14.97%
Eli Lilly And Company	-3.55%	25.87%	94.52%	298.3%	531.94%
Johnson & Johnson	-3.65%	-1.1%	-8.63%	-8.87%	7.44%
Merck & Co. Inc.	1.25%	23.15%	9.44%	63.65%	69.78%
Abbvie Inc	-5.04%	15.88%	3.33%	52.2%	115.51%
Pfizer Inc.	-4.05%	-13.51%	-34.05%	-31.95%	-33.15%

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sanofi	Buy	$117.7B	14.97%	20.59	11.73%
Eli Lilly And Company	Buy	$695.3B	531.94%	126.53	15.36%
Johnson & Johnson	Hold	$359.3B	7.44%	20.07	47.37%
Merck & Co. Inc.	Buy	$321.5B	69.78%	906.71	0.61%
Abbvie Inc	Buy	$297.3B	115.51%	61.72	8.95%
Pfizer Inc.	Buy	$148.7B	-33.15%	70.97	3.62%

Organization	Sanofi
Employees	86088
CEO	Mr. Paul Hudson
Industry	Health Technology